Celltrion Inc. (068270)
KRX
Closed
Aug 25, 2026
Day's Range
188,900.0052 wk Range
158,500.00Overview - 068270 - Celltrion Inc.
Key Statistics
Valuation
Enterprise Value
46.86T
P/E (Trailing)
‪42.64‬
P/E (Forward)
‪25.12‬
PEG Ratio
‪0.21‬
Price / Sales (TTM)
‪9.08‬
Price / Book
‪2.44‬
EV / EBITDA
‪25.48‬
Profitability
Gross Margin
‪59.89%‬
Profit Margin
‪32.18%‬
Operating Margin
‪32.41%‬
Return on Assets
‪4.36%‬
Return on Equity
‪9.11%‬
Ownership
Shares Outstanding
229.64M
Float
152.01M
Held by Insiders
‪36.17%‬
Held by Institutions
‪20.38%‬
Price stats
50-Day Avg
‪180,714.00‬
200-Day Avg
‪189,166.73‬
Dividends
Payout Ratio
‪10.42%‬
Analyst Consensus
23 analysts
Average price target
‪₩ 265,451.94‬Market Cap - 068270 - Celltrion Inc.
Peers - 068270 - Celltrion Inc.
Peer Comparison
Compared with companies in Biotechnology listed on KRX.
- 068270KRXCelltrion Inc.44.48TMarket Cap+14.43%52-week change43.64P/E (Trailing)‪32.18%‬Profit Margin
- 207940KRXSamsung Biologics Co., Ltd.73.37TMarket Cap+1.05%52-week change59.52P/E (Trailing)‪38.74%‬Profit Margin
- 196170KRXALTEOGEN Inc.21.25TMarket Cap-6.51%52-week change149.70P/E (Trailing)‪63.89%‬Profit Margin
- 0126Z0KRXSamsung Epis Holdings Co., Ltd.9.16TMarket Cap-19.00%52-week change—P/E (Trailing)‪33.89%‬Profit Margin
- 326030KRXSk Biopharmaceuticals Co., Ltd.6.76TMarket Cap-16.32%52-week change25.34P/E (Trailing)‪44.13%‬Profit Margin
- 028300KRXHLB Co., Ltd.5.08TMarket Cap+1.04%52-week change-22.80P/E (Trailing)‪-228.04%‬Profit Margin
- 214450KRXPharma Research Products Co., Ltd4.30TMarket Cap-69.84%52-week change26.08P/E (Trailing)‪31.21%‬Profit Margin
Profile Summary - 068270 - Celltrion Inc.
About
Celltrion Inc. is one of the world's formidable players in the biopharmaceutical industry, focusing on the development, manufacture, and commercialization of innovative therapies. Known for its monoclonal antibody biosimilars, Celltrion serves critical therapeutic areas such as oncology, autoimmune disorders, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
